Übersetzung für "Proprietary drug " (Englisch → Französisch) :

9. Stresses that the transfer of clean-energy technology to developing countries is central to tackling climate change and meeting the Millennium Development Goals; notes that at the 2005 Gleneagles summit, G8 leaders recognised the need for greater international co-operation and coordination of research and development of energy technologies; notes further that, at the same time, the Heads of Government of Brazil, Mexico, South Africa, China and India issued a joint statement with a view to building a new paradigm for international cooperation in the future, including improved participation in RD, international funding for technology transfer, and a concerted effort to address issues relating to Intellectual Property Rights (IPR); calls ...[+++] on the Commission to address IPR-related barriers to the acquisition of existing proprietary clean-energy technology through dialogue on the basis of further work analysing how international funds and public-private initiatives have fostered technology transfer covered by IPRs in other fields; calls on the Commission to explore the potential for new kinds of global public-private-partnerships in technologies to tackle climate change, drawing experience from international agreements to support IPR access to anti-retroviral drugs for developing countries.

All Member States are increasingly making use of various cost-absorbing mechanisms such as patients’ own participation in hospital, medical or drug costs, special agreements on drugs (price maintenance, or the use of proprietary medicines) or contracts between the purchasers of health services and service providers (fixed annual budgets or diagnosis-related pricing groups for hospitals).

For these industries which are driven by major and rapid technological innovation, the new intellectual property agreement will be of particular benefit in ensuring that the many proprietary aspects of drug and medical devices are not copied by offshore competitors.

Whereas it is also advisable to make the packaging of certain proprietary medicinal products, particularly sought after by drug addicts, less distinctive by removing the obligation to place a special mark on the outer packaging and the container of proprietary medicinal products classified as narcotics;